Benzinga | Feb 16, 2021 09:32AM EST

Co-Diagnostics, Inc. To Present On Direct Saliva Testing Technology At Molecular Med Tri-Con Feb. 16-18

SALT LAKE CITY, Feb. 16, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be presenting on direct saliva testing for COVID-19 at the 28th Annual International Molecular Medicine Tri-Conference, held virtually on February 16-18, 2021.